EZH2 and colonic neoplasm: Polycomb group protein enhancer of zeste homologue 2 (Ezh2) enhances stem cell-like properties in colon cancer by activation of the p21cip1-Wnt/β-catenin signaling pathway, thus leading to cell cycle arrest at the G1/S phase [24].